Peptide therapy TikTok claims: what the science actually supports

What did @taylorreidcoachin actually say?

The creator claims that 5-Amino-1MQ helps with "fat oxidation" by supporting mitochondrial health, which raises energy levels throughout the day and prevents the energy crashes that trigger food cravings, mindless snacking, and emotional eating. They connect these effects in a causal chain: better fat burning leads to steadier energy, and steadier energy leads to fewer urges to overeat. They also disclose personal struggles with emotional eating, which is a notable moment of honesty in a content space that often skips that kind of transparency.

What they did not say: any specific dose, any disease it treats, or that it cures anything. That restraint matters.

Does the science back this up?

Partially, but the human data is nearly nonexistent. The fat oxidation claim has a plausible biological mechanism, but calling it established science would be a significant overstatement.

5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that regulates NAD+ availability and metabolic rate in adipose tissue. Inhibit NNMT, raise NAD+, improve mitochondrial function, increase fat oxidation. That chain of reasoning is supported by preclinical work. A 2021 study by Neelakantan et al. in Nature Communications showed NNMT inhibition reduced fat mass and improved metabolic markers in mice without caloric restriction. Genuinely interesting. But no peer-reviewed human clinical trials on 5-Amino-1MQ exist as of early 2025. The leap from mouse adipose tissue to human energy crashes is not a small one, and the creator presents this as more settled than the literature allows.

What did they get wrong (or right)?

The underlying biology is directionally correct. The confidence level attached to it is not. Give credit for the mechanism, push back on the certainty.

The link between mitochondrial fat oxidation and metabolic flexibility is legitimate science. When cells efficiently oxidize fatty acids for fuel, blood glucose stays more stable, and that does reduce glucose-driven energy dips. Research by Goodpaster and Sparks published in Cell Metabolism in 2017 confirms that metabolic flexibility, meaning the ability to switch between fuel sources, is associated with more stable energy and reduced appetite signaling. The creator gets that connection right in spirit. What they get wrong is presenting 5-Amino-1MQ as if it reliably delivers this outcome in humans. There is also a terminology slip: the creator says "monochondria" when they mean mitochondria. Minor, but in a credibility-sensitive space it is worth flagging. The emotional eating framing is the most grounded part of the video because it connects abstract biochemistry to real behavioral patterns and is personally disclosed rather than just asserted.

What should you actually know?

5-Amino-1MQ is a research compound. It is not FDA-approved. Human safety and efficacy data are sparse. Mechanistic plausibility is not the same as clinical proof.

If metabolic health and energy stability are your actual goals, there are interventions with real human trial data: zone 2 aerobic exercise, dietary strategies that improve insulin sensitivity, and for people with obesity or type 2 diabetes, GLP-1 receptor agonists have a substantial evidence base. 5-Amino-1MQ may eventually earn a place in that list, but right now it is being used off-label based primarily on animal data and anecdote. If a provider is offering it to you without disclosing the absence of human clinical trials, that is worth pushing back on. The energy crash and craving cycle the creator describes is a real phenomenon rooted in metabolic inflexibility. The question is not whether that cycle exists. The question is whether this particular compound reliably breaks it in humans. That answer is not yet available.